LivaNova (LIVN) Equity Average (2014 - 2026)
LivaNova recorded quarterly Equity Average of $1.2 billion in Q1 2026, up 2.29% quarter-over-quarter from $1.2 billion in Q4 2025, and up 2.41% year-over-year from $1.2 billion in Q1 2025.
LivaNova's Equity Average history runs 13 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Equity Average rose 2.41% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 2.41% YoY), while the FY2025 annual figure was $1.3 billion, down 2.99% from the prior year.
- Equity Average came in at $1.2 billion for Q1 2026 at LivaNova, up from $1.2 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.3 billion in Q4 2024 to a low of $1.1 billion in Q2 2025.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Equity Average.
- Across the five-year window, Equity Average increased 23.52% in 2022 and decreased 12.46% in 2025, its largest moves.
- LivaNova's Equity Average stood at $1.2 billion in 2022, then climbed by 6.31% to $1.3 billion in 2023, then gained by 5.08% to $1.3 billion in 2024, then dropped by 10.38% to $1.2 billion in 2025, then advanced by 2.29% to $1.2 billion in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $1.2 billion, $1.2 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.18 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.28 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.18 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.29 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Sep 30, 2021 | 1.16 Bn |
| Jun 30, 2021 | 1.04 Bn |
| Mar 31, 2021 | 1.08 Bn |
| Dec 31, 2020 | 1.23 Bn |
| Sep 30, 2020 | 1.34 Bn |
| Jun 30, 2020 | 1.36 Bn |
| Mar 31, 2020 | 1.39 Bn |
| Dec 31, 2019 | 1.44 Bn |
| Sep 30, 2019 | 1.49 Bn |
| Jun 30, 2019 | 1.49 Bn |
| Mar 31, 2019 | 1.49 Bn |
| Dec 31, 2018 | 1.64 Bn |
| Sep 30, 2018 | 1.78 Bn |
| Jun 30, 2018 | 1.80 Bn |
| Mar 31, 2018 | 1.82 Bn |
| Dec 31, 2017 | 926.89 Mn |
| Sep 30, 2017 | 19.19 Mn |
| Jun 30, 2017 | -28.38 Mn |
| Mar 31, 2017 | 825.12 Mn |
| Dec 31, 2016 | 852.04 Mn |
| Sep 30, 2016 | -13.86 Mn |
| Jun 30, 2016 | -15.76 Mn |
| Mar 31, 2016 | 902.42 Mn |
| Dec 31, 2015 | 1.04 Bn |
| Oct 24, 2014 | 264.50 Mn |